search
Back to results

Discussing COVID-19 Vaccines in Private Facebook Groups

Primary Purpose

COVID-19

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Gist messages on COVID-19 vaccination
COVID-19 vaccine information
Sponsored by
George Washington University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for COVID-19 focused on measuring vaccine hesitancy, social media, health behavior

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • reside in the U.S.
  • unvaccinated from COVID-19
  • Use Facebook regularly (at least 1/day)

Exclusion Criteria:

  • age <18 years
  • do not reside in the U.S.
  • vaccinated from COVID-19
  • do not use Facebook regularly (at least 1/day)

Sites / Locations

  • George Washington University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Gist

Information

Arm Description

Gist-based messages on COVID-19 vaccination and moderated group discussions in a private Facebook group

Link to Facebook COVID-19 Information Center

Outcomes

Primary Outcome Measures

Engagement and satisfaction with the program
Engagement includes participation in the Facebook group; satisfaction=self-rated overall satisfaction with the program (7-point scale)

Secondary Outcome Measures

Proportion of participants getting the COVID-19 vaccine
self-reported vaccination status
Change in COVID-19 vaccination intention
Self-reported intention to get the COVID-19 vaccine (7-point scale)
Change in intention to encourage others to get the COVID-19 vaccine
Self-reported intention to encourage others to get the COVID-19 vaccine (7-point scale)
Change in COVID-19 vaccine confidence
Self-reported confidence in the COVID-19 vaccine (5-point scale)
Change in general vaccine confidence
Self-reported confidence in vaccines (7-point scale)
Change in vaccine hesitancy
Self-reported vaccine hesitancy (7-point scale

Full Information

First Posted
June 15, 2022
Last Updated
June 15, 2022
Sponsor
George Washington University
search

1. Study Identification

Unique Protocol Identification Number
NCT05422898
Brief Title
Discussing COVID-19 Vaccines in Private Facebook Groups
Official Title
Empathic Engagement With the COVID-19 Vaccine Hesitant in Private Facebook Groups
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
January 17, 2022 (Actual)
Primary Completion Date
April 4, 2022 (Actual)
Study Completion Date
April 4, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
George Washington University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19
Keywords
vaccine hesitancy, social media, health behavior

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
508 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Gist
Arm Type
Experimental
Arm Description
Gist-based messages on COVID-19 vaccination and moderated group discussions in a private Facebook group
Arm Title
Information
Arm Type
Placebo Comparator
Arm Description
Link to Facebook COVID-19 Information Center
Intervention Type
Behavioral
Intervention Name(s)
Gist messages on COVID-19 vaccination
Intervention Description
Participants will receive gist-based messages on COVID-19 vaccines and have their concerns addressed by a group moderator
Intervention Type
Behavioral
Intervention Name(s)
COVID-19 vaccine information
Intervention Description
Participants will receive a link to the Facebook COVID-19 Information Center via a private Facebook Group
Primary Outcome Measure Information:
Title
Engagement and satisfaction with the program
Description
Engagement includes participation in the Facebook group; satisfaction=self-rated overall satisfaction with the program (7-point scale)
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Proportion of participants getting the COVID-19 vaccine
Description
self-reported vaccination status
Time Frame
4 weeks
Title
Change in COVID-19 vaccination intention
Description
Self-reported intention to get the COVID-19 vaccine (7-point scale)
Time Frame
4 weeks
Title
Change in intention to encourage others to get the COVID-19 vaccine
Description
Self-reported intention to encourage others to get the COVID-19 vaccine (7-point scale)
Time Frame
4 weeks
Title
Change in COVID-19 vaccine confidence
Description
Self-reported confidence in the COVID-19 vaccine (5-point scale)
Time Frame
4 weeks
Title
Change in general vaccine confidence
Description
Self-reported confidence in vaccines (7-point scale)
Time Frame
4 weeks
Title
Change in vaccine hesitancy
Description
Self-reported vaccine hesitancy (7-point scale
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: reside in the U.S. unvaccinated from COVID-19 Use Facebook regularly (at least 1/day) Exclusion Criteria: age <18 years do not reside in the U.S. vaccinated from COVID-19 do not use Facebook regularly (at least 1/day)
Facility Information:
Facility Name
George Washington University
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20052
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Discussing COVID-19 Vaccines in Private Facebook Groups

We'll reach out to this number within 24 hrs